|4Nov 12, 6:21 PM ET

International Stem Cell CORP 4

4 · International Stem Cell CORP · Filed Nov 12, 2014

Insider Transaction Report

Form 4
Period: 2014-11-10
Craw John Simon
Executive Vice President
Transactions
  • Award

    Stock Option (Right to Buy)

    2014-11-10+60,00060,000 total
    Exercise: $0.11Exp: 2024-11-10Common Stock (60,000 underlying)
Footnotes (1)
  • [F1]1/4th of the shares underlying such options shall vest on November 10, 2015, and the remaining shares in equal monthly installments over a period of three years.

Documents

1 file
  • 4
    isco_f4-craw.xmlPrimary

    OWNERSHIP DOCUMENT